Swissmedic Vigilance News Edition 22 – May 2019

Keywords in this edition: Current case report, WHO - Annual pharmacovigilance meeting, Medicinal product risks, Information for patients, Collaboration on the safety of medicines


Report regarding suspected illegal trading in medicinal products

As of 1 January 2019, anyone who produces, sells or distributes medicinal products is required by law to report to Swissmedic any suspicion of illegal trading in such products.


Batch recall – Co-Amoxicillin Sandoz 312,5, Pulver zur Zubereitung einer Suspension

Rückruf der Charge HX3438 bis auf Stufe Patient


Classification of permethrin-containing preparations for topical application in animals

These products shall in future come under the therapeutic products legislation in Switzerland


DHPC – Tecentriq® (Atezolizumab)

Fälle von immunbedingter Myositis im Zusammenhang mit Tecentriq®

Direct links

Stay up to date

Incident reporting


Reporting undesirable effects

Medical devices

Reporting incidents & FSCAs




Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019


What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.

Swissmedic, Swiss Agency for Therapeutic Products


Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...